• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tau蛋白与导致突触功能障碍的激酶/磷酸酶协同作用。

Tau Acts in Concert With Kinase/Phosphatase Underlying Synaptic Dysfunction.

作者信息

Fan Xing, Xia Liye, Zhou Zheng, Qiu Yanyan, Zhao Chenhao, Yin Xiaomin, Qian Wei

机构信息

Department of Biochemistry and Molecular Biology, Medical School, Jiangsu Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education of China, Co-innovation Center of Neuroregeneration, Nantong University, Nantong, China.

NMPA Key Laboratory for Research and Evaluation of Tissue Engineering Technology Products, Nantong University, Nantong, China.

出版信息

Front Aging Neurosci. 2022 May 27;14:908881. doi: 10.3389/fnagi.2022.908881. eCollection 2022.

DOI:10.3389/fnagi.2022.908881
PMID:35711910
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9196307/
Abstract

Alzheimer's disease (AD) is characterized by two pathological features: neurofibrillary tangles (NFTs), formed by microtubule-associated protein tau, and abnormal accumulation of amyloid-β (Aβ). Multiple evidence placed synaptic tau as the vital fact of AD pathology, especially at the very early stage of AD. In the present review, we discuss tau phosphorylation, which is critical for the dendritic localization of tau and synaptic plasticity. We review the related kinases and phosphatases implicated in the synaptic function of tau. We also review the synergistic effects of these kinases and phosphatases on tau-associated synaptic deficits. We aim to open a new perspective on the treatment of AD.

摘要

阿尔茨海默病(AD)具有两种病理特征:由微管相关蛋白tau形成的神经原纤维缠结(NFTs),以及淀粉样β蛋白(Aβ)的异常积累。多项证据表明,突触中的tau是AD病理的关键因素,尤其是在AD的极早期阶段。在本综述中,我们讨论了tau磷酸化,它对于tau在树突中的定位和突触可塑性至关重要。我们回顾了与tau突触功能相关的激酶和磷酸酶。我们还回顾了这些激酶和磷酸酶对tau相关突触缺陷的协同作用。我们旨在为AD的治疗开辟一个新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06b7/9196307/c639ed0b0140/fnagi-14-908881-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06b7/9196307/ca63747fac9e/fnagi-14-908881-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06b7/9196307/c639ed0b0140/fnagi-14-908881-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06b7/9196307/ca63747fac9e/fnagi-14-908881-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06b7/9196307/c639ed0b0140/fnagi-14-908881-g0002.jpg

相似文献

1
Tau Acts in Concert With Kinase/Phosphatase Underlying Synaptic Dysfunction.Tau蛋白与导致突触功能障碍的激酶/磷酸酶协同作用。
Front Aging Neurosci. 2022 May 27;14:908881. doi: 10.3389/fnagi.2022.908881. eCollection 2022.
2
Dendritic/Post-synaptic Tau and Early Pathology of Alzheimer's Disease.树突状/突触后 Tau 蛋白与阿尔茨海默病的早期病理学
Front Mol Neurosci. 2021 Jun 25;14:671779. doi: 10.3389/fnmol.2021.671779. eCollection 2021.
3
Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.突触线粒体:阿尔茨海默病中淀粉样β和tau 的早期靶标。
J Alzheimers Dis. 2021;84(4):1391-1414. doi: 10.3233/JAD-215139.
4
The Role of Amyloid-Beta and Tau in the Early Pathogenesis of Alzheimer's Disease.β-淀粉样蛋白和 Tau 在阿尔茨海默病早期发病机制中的作用。
Med Sci Monit. 2021 Sep 2;27:e933084. doi: 10.12659/MSM.933084.
5
G protein-coupled receptor kinases are associated with Alzheimer's disease pathology.G 蛋白偶联受体激酶与阿尔茨海默病病理有关。
Neuropathol Appl Neurobiol. 2021 Dec;47(7):942-957. doi: 10.1111/nan.12742. Epub 2021 Jul 19.
6
[Pathological changes induced by amyloid-β in Alzheimer's disease].[阿尔茨海默病中β-淀粉样蛋白诱导的病理变化]
Yakugaku Zasshi. 2011 Jan;131(1):3-11. doi: 10.1248/yakushi.131.3.
7
Tau: The Center of a Signaling Nexus in Alzheimer's Disease.tau蛋白:阿尔茨海默病信号枢纽的核心
Front Neurosci. 2016 Feb 9;10:31. doi: 10.3389/fnins.2016.00031. eCollection 2016.
8
Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.微管相关蛋白tau磷酸化在阿尔茨海默病中的作用。
J Huazhong Univ Sci Technolog Med Sci. 2017 Jun;37(3):307-312. doi: 10.1007/s11596-017-1732-x. Epub 2017 Jun 6.
9
Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.阿尔茨海默病发病机制中的氧化应激与突触功能障碍:理解治疗策略
Mol Neurobiol. 2016 Jan;53(1):648-661. doi: 10.1007/s12035-014-9053-6. Epub 2014 Dec 17.
10
Aβ Influences Cytoskeletal Signaling Cascades with Consequences to Alzheimer's Disease.β-淀粉样蛋白影响细胞骨架信号级联反应,进而导致阿尔茨海默病。
Mol Neurobiol. 2015 Dec;52(3):1391-1407. doi: 10.1007/s12035-014-8913-4. Epub 2014 Oct 26.

引用本文的文献

1
Exosomal Dynamics and Brain Redox Imbalance: Implications in Alzheimer's Disease Pathology and Diagnosis.外泌体动力学与脑氧化还原失衡:对阿尔茨海默病病理学及诊断的影响
Antioxidants (Basel). 2024 Mar 5;13(3):316. doi: 10.3390/antiox13030316.

本文引用的文献

1
Masitinib for the treatment of Alzheimer's disease.马斯替宾治疗阿尔茨海默病。
Neurodegener Dis Manag. 2021 Aug;11(4):263-276. doi: 10.2217/nmt-2021-0019. Epub 2021 Aug 20.
2
Dendritic/Post-synaptic Tau and Early Pathology of Alzheimer's Disease.树突状/突触后 Tau 蛋白与阿尔茨海默病的早期病理学
Front Mol Neurosci. 2021 Jun 25;14:671779. doi: 10.3389/fnmol.2021.671779. eCollection 2021.
3
GSK3α, not GSK3β, drives hippocampal NMDAR-dependent LTD via tau-mediated spine anchoring.GSK3α 而非 GSK3β 通过 tau 介导的棘突锚定驱动海马 NMDA 受体依赖性 LTD。
EMBO J. 2021 Jan 15;40(2):e105513. doi: 10.15252/embj.2020105513. Epub 2020 Nov 16.
4
Discovery and Functional Characterization of hPT3, a Humanized Anti-Phospho Tau Selective Monoclonal Antibody.发现并功能表征 hPT3:一种人源化抗磷酸化 Tau 选择性单克隆抗体。
J Alzheimers Dis. 2020;77(4):1397-1416. doi: 10.3233/JAD-200544.
5
The physiological roles of tau and Aβ: implications for Alzheimer's disease pathology and therapeutics.tau 和 Aβ 的生理作用:对阿尔茨海默病病理和治疗的启示。
Acta Neuropathol. 2020 Oct;140(4):417-447. doi: 10.1007/s00401-020-02196-w. Epub 2020 Jul 29.
6
Reduction of advanced tau-mediated memory deficits by the MAP kinase p38γ.p38γ 丝裂原活化蛋白激酶减少晚期 tau 介导的记忆缺陷。
Acta Neuropathol. 2020 Sep;140(3):279-294. doi: 10.1007/s00401-020-02191-1. Epub 2020 Jul 29.
7
Sulfhydration of AKT triggers Tau-phosphorylation by activating glycogen synthase kinase 3β in Alzheimer's disease.阿尔茨海默病中 AKT 的巯基化通过激活糖原合酶激酶 3β 引发 Tau 磷酸化。
Proc Natl Acad Sci U S A. 2020 Feb 25;117(8):4418-4427. doi: 10.1073/pnas.1916895117. Epub 2020 Feb 12.
8
Advances and considerations in AD tau-targeted immunotherapy.AD tau 靶向免疫疗法的进展与思考。
Neurobiol Dis. 2020 Feb;134:104707. doi: 10.1016/j.nbd.2019.104707. Epub 2019 Dec 10.
9
A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity.一种 Tau-SH3 相互作用的肽抑制剂可改善淀粉样β毒性。
Neurobiol Dis. 2020 Feb;134:104668. doi: 10.1016/j.nbd.2019.104668. Epub 2019 Nov 5.
10
Tau inhibits PKA by nuclear proteasome-dependent PKAR2α elevation with suppressed CREB/GluA1 phosphorylation.tau 通过核蛋白酶体依赖性的 pkara2α 升高抑制 pkka,同时抑制 creb/glua1 磷酸化。
Aging Cell. 2020 Jan;19(1):e13055. doi: 10.1111/acel.13055. Epub 2019 Oct 31.